Home › Ischemic Stroke › New York › Greenburgh
Ischemic Stroke clinical trials in Greenburgh, NY
4 studies for Ischemic Stroke are looking for participants at sites in and around Greenburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- White Plains Hospital, White Plains · 4 mi away
- Westchester Medical Center, Valhalla · 5 mi away
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
RecruitingObservational study
- Westchester Medical Center, Valhalla · 5 mi away
Vivistim Registry for Paired VNS Therapy (GRASP)
RecruitingObservational study
- Burke Rehabilitation Hospital, White Plains · 4 mi away
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Recruiting
- Burke Rehabilitation Hospital, White Plains · 4 mi away
About Ischemic Stroke
A stroke is a medical emergency that should be treated immediately. Read about the causes, symptoms and treatments for an ischemic stroke.
More about Ischemic Stroke on MedlinePlus
Ischemic Stroke trials in other cities
- New York City, NY18 studies
- Houston, TX18 studies
- Boston, MA17 studies
- Los Angeles, CA14 studies
- Philadelphia, PA13 studies
- Atlanta, GA13 studies
- Chicago, IL12 studies
- Baltimore, MD11 studies
- Pittsburgh, PA11 studies
- Cincinnati, OH11 studies
- St. Louis, MO11 studies
- Salt Lake City, UT10 studies
Other studies in Greenburgh
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer28 studies
- Acute Myeloid Leukemia18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma13 studies
- Colorectal Cancer11 studies
- Metastatic Cancer11 studies
- Endometrial Cancer11 studies
- Bladder Cancer10 studies
- Head and Neck Squamous Cell Carcinoma9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.